Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy

Clinical Breast Cancer

Volumn 13, Issue 5, 2013, Pages 335-343

  Saigal, Kunal ^a   Hurley, Judith ^a   Takita, Cristiane ^a   Reis, Isildinha M ^a   Zhao, Wei ^a   Rodgers, Steven E ^a   Wright, Jean L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Inflammatory breast cancer; Locoregional recurrence; Neoadjuvant chemotherapy; Postmastectomy radiation

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC METAL COMPLEX; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; ARTICLE; AXILLARY LYMPH NODE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY BREAST CANCER; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; THORAX WALL; TREATMENT FAILURE; TREATMENT RESPONSE;

BREAST CANCER; INFLAMMATORY BREAST CANCER; LOCOREGIONAL RECURRENCE; NEOADJUVANT CHEMOTHERAPY; POSTMASTECTOMY RADIATION;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFLAMMATORY BREAST NEOPLASMS; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 84883768031     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2013.04.002     Document Type: Article

References (18)

1. F. Bozzetti, R. Saccozzi, and M. De Lena Inflammatory cancer of the breast: analysis of 114 cases J Surg Oncol 18 1981 355 361
2. W.W. Thomas Jr., M.D. McNeese, and G.H. Fletcher Multimodal treatment for inflammatory breast cancer Int J Radiat Oncol Biol Phys 17 1989 739 745
3. I.J. Bristol, W.A. Woodward, and E.A. Strom Locoregional treatment outcomes after multimodality management of inflammatory breast cancer Int J Radiat Oncol Biol Phys 72 2008 474 484
4. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106
5. R.Y. Fleming, L. Asmar, and A.U. Buzdar Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma Ann Surg Oncol 4 1997 452 461
6. A. Hasbini, C. Le Pechoux, and B. Roche Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer [in French with English abstract] Cancer Radiother 4 2000 265 273
7. F. Thomas, R. Arriagada, and M. Spielmann Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy Cancer 76 1995 2286 2290
8. S. Rehman, C.A. Reddy, and R.D. Tendulkar Modern outcomes of inflammatory breast cancer Int J Radiat Oncol Biol Phys 84 2012 619 624
9. K.W. Hance, W.F. Anderson, and S.S. Devesa Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute J Natl Cancer Inst 97 2005 966 975
10. M.C. Abramowitz, T. Li, and M. Morrow Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation Am J Clin Oncol 32 2009 30 33
11. Breast cancer. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology - v.2.2013. National Comprehensive Cancer Network [Web site]. Available at: http://www.nccn.org/professionals/physician-gls/pdf/breast. pdf. Access: April 12, 2013.
12. J.L. Wright, C. Takita, and I.M. Reis Predictors of locoregional outcome in patients receiving neoadjuvant therapy and post-mastectomy radiation Cancer 119 2013 16 25
13. The R Development Core Team. R: A Language and Environment for Statistical Computing. (http://www.R-project.org/) R Foundation for Statistical Computing. Version 2.8.0 (2008-10-20) ISBN 3-900051-07-0.
14. M. Cristofanilli, V. Valero, and A.U. Buzdar Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease Cancer 110 2007 1436 1444
15. S. Damast, A.Y. Ho, and L. Montgomery Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era Int J Radiat Oncol Biol Phys 77 2010 1105 1112
16. X. Wang, T.K. Yu, and M. Salehpour Breast cancer regional radiation fields for supraclavicular and axillary lymph node treatment: is a posterior axillary boost field technique optimal? Int J Radiat Oncol Biol Phys 74 2009 86 91
17. J. Li, A.M. Gonzalez-Angulo, and P.K. Allen Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer Oncologist 16 2011 1675 1683
18. J.A. Zell, W.Y. Tsang, and T.H. Taylor Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry Breast Cancer Res 11 2009 R9